← All organizations
Green Cross Corporation
For profit
Also known as: GC Biopharma Corp | GC Biopharma Corp. | GC Cell Corporation | GC Pharma | Green Cross Cell Corporation | Green Cross Corporation | Green Cross LabCell Corporation | Green Cross Wellbeing | The Blood Plasma Corporation of Japan
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2004Last known activity
Mar 31, 2026
Acquired by Welfide → Mitsubishi Tanabe on Jan 1, 1998
Timeline
1950s
- Jan 1, 1950
Green Cross Corporation— Founded
1990s
- Jan 1, 1998
Welfide— Acquired By
2000s
- Jan 1, 2001
Mitsubishi Tanabe— Now
Drugs by trial phase (80 distinct, 108 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (18 own, 0 via acquisition)
Phase 2 (27 own, 0 via acquisition)
Phase 1 (17 own, 0 via acquisition)
Other trials (10 own, 0 via acquisition)
Indications
Studied for
- Anthrax
- Ascites
- Bacterial Infections
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Cerebral Infarction
- Chickenpox
- Colorectal Neoplasms
- Diphtheria
- Encephalitis
- Fabry Disease
- Fatigue
- Fatigue Syndrome, Chronic
- Gastritis
- Glioblastoma
- Hashimoto Disease
- Hemophilia A
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Herpes Zoster
- Immunologic Deficiency Syndromes
- Infarction
- Influenza, Human
- Liver Neoplasms
- Lymphoma
- Lymphoma, Non-Hodgkin
- Mucocutaneous Lymph Node Syndrome
- Mucopolysaccharidoses
- Mucopolysaccharidosis II
- Neoplasm Metastasis
- Neoplasms
- Neutropenia
- Osteoarthritis
- Osteoarthritis, Knee
- Pancreatic Neoplasms
- Purpura, Thrombocytopenic, Idiopathic
- Sepsis
- Shock
- Shock, Septic
- Stomach Neoplasms
- Syndrome
- Tetanus
- Tetany
- Thrombocytopenia
- Toxemia
- Tuberculosis
- Vaccinia
- Whooping Cough
Recent trials (50)
- NCT07054099Lead sponsorPhase 3Mar 31, 2026
- NCT06997627Lead sponsorPhase 1/Phase 2Jun 5, 2025
- NCT06858397Lead sponsorPhase 1/Phase 2May 14, 2025
- NCT06699771Lead sponsorPhase 1Dec 31, 2024
- NCT06567769Lead sponsorPhase 1Nov 30, 2024
- NCT06341647Lead sponsorPhase 1Oct 31, 2024
- NCT06493799Lead sponsorPhase 3Jul 1, 2024
- NCT05664152Lead sponsorN/AFeb 28, 2023
- NCT05729386Lead sponsorPhase 1Feb 6, 2023
- NCT05686759Lead sponsorPhase 3Jan 18, 2023
- NCT05703984Lead sponsorPhase 1Jan 17, 2023
- NCT05632341Lead sponsorN/ADec 20, 2022
- NCT05528705Lead sponsorN/ASep 20, 2022
- NCT05422482Lead sponsorPhase 1Sep 20, 2022
- NCT05493631Lead sponsorPhase 1Aug 24, 2022
Details
- Founded
- Osaka, JP Jan 1, 1950
- Last known activity
- Mar 31, 2026
Notes
--- Pre-folding founded info: 1964-01-01 Osaka JP https://en.wikipedia.org/wiki/Mitsubishi_Tanabe_Pharma ---